Nina D'Abreo, MD, discusses the importance of considering a patient’s medical history and preferences when deciding on a treatment course in HER2-positive breast cancer and highlights the important role of surgeons within breast cancer treatment.
David R. Wise, MD, PhD, discusses his presentation from an OncLive® State of the Science Summit™ on prostate cancer, during where he discussed the treatment of patients with metastatic castration-resistant prostate cancer.
Yelena Novik, MD, discusses advancements and emerging trends that have been seen in the treatment of patients with advanced estrogen-receptor–positive breast cancer, citing clinical trials that have helped push the treatment armamentarium forward.